Vicapsys Life Sciences, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vicapsys Life Sciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
  • Vicapsys Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$236K, a 2.01% increase year-over-year.
  • Vicapsys Life Sciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$1.35M, a 24.8% decline year-over-year.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$1.18M, a 20% decline from 2022.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$985K, a 316% decline from 2021.
  • Vicapsys Life Sciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$237K, a 69.1% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.35M -$236K +$4.83K +2.01% Jul 1, 2024 Sep 30, 2024 10-Q 2025-01-10
Q2 2024 -$1.35M -$190K -$54.4K -40.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-01-10
Q1 2024 -$1.3M -$327K -$116K -54.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-01-10
Q4 2023 -$1.18M -$595K -$102K -20.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-10-21
Q3 2023 -$1.08M -$240K -$95.3K -65.7% Jul 1, 2023 Sep 30, 2023 10-Q 2025-01-10
Q2 2023 -$985K -$136K +$44.4K +24.6% Apr 1, 2023 Jun 30, 2023 10-Q 2025-01-10
Q1 2023 -$1.03M -$211K -$44.2K -26.5% Jan 1, 2023 Mar 31, 2023 10-Q 2025-01-10
Q4 2022 -$985K -$493K -$389K -374% Oct 1, 2022 Dec 31, 2022 10-K 2024-10-21
Q3 2022 -$596K -$145K -$33.9K -30.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$562K -$180K -$108K -150% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$454K -$167K -$217K -433% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$237K -$104K -$23.3K -28.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-14
Q3 2021 -$214K -$111K -$22K -24.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$192K -$72.1K +$160K +68.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-21
Q1 2021 -$351K $50.2K +$415K Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-21
Q4 2020 -$766K -$80.5K +$169K +67.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-16
Q3 2020 -$935K -$89.2K +$380K +81% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$1.32M -$232K +$16.5K +6.63% Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-20
Q1 2020 -$1.33M -$364K +$78.2K +17.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-09-20
Q4 2019 -$1.41M -$250K Oct 1, 2019 Dec 31, 2019 10-K 2021-09-17
Q3 2019 -$469K Jul 1, 2019 Sep 30, 2019 10-Q 2021-09-13
Q2 2019 -$248K Apr 1, 2019 Jun 30, 2019 10-Q 2021-09-13
Q1 2019 -$443K Jan 1, 2019 Mar 31, 2019 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.